RSV Vaccine Shortage Hits Infants: CDC Alert
TL/DR -
The monoclonal antibody Beyfortus, used to prevent serious lung disease caused by RSV in infants, is in short supply with demand outpacing expectations. The CDC has issued a health advisory recommending available doses be prioritized for high-risk infants including those under 6 months of age and those with underlying conditions. The…